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The search for newer species-specific antigens from 
prevalent strains of Mycobacterium tuberculosis (Mtb) 
associated with active disease will add substantially to 
improve the presently available diagnostic tools. We 
studied the protein profiles of 13 sonicate antig ns (S1–
S13) prepared from the prevalent strains. The hu-
moral immune response was also studied in 30 normal 
and 30 tuberculosis (TB) patients. The sonicate antigens 
S10 and S12 showed maximum differential protein 
bands in low molecular mass region of 10–30kDa on 
SDS–PAGE. Our ELISA results showed significant 
increase in Mtb-specific IgG antibodies in TB plasma 
for H37Rv, followed by PPD, S1 and S10 antigens. 
Immunoblot analysis of S10 antigen showed specific 
recognition pattern at low molecular mass regionby TB 
plasma alone with 12–77% positivity of protein bands. 
Thus the sonicate antigen S10 was found to be dis-
criminatory by ELISA and Western blot and hence a 
good candidate for further purification of its individ-
ual proteins to be evaluated for diagnosis.  
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FOR several decades, rigorous investigations are being 
performed to understand the humoral immune response to 
infection by Mycobacterium tuberculosis (Mtb). The pri-
mary purpose of these investigations was to devise specific 
and sensitive serodiagnosis for tuberculosis (TB)1–6. Many 
studies have shown the diagnostic values of native7,8 and 
recombinant9–11 antigens of Mtb, but single antigen-based 
assays could not achieve satisfactory serodiagnostic per-
formance12,13. Moreover, these studies have used antig nic 
components from the laboratory strains of Mtb (H37Rv, 
H37Ra) and non-human strains (M. bovis, M. bovis BCG) 
for evaluation. Most of the non-specificity observed in 
these assays was due to their widely shared antigens 
among species and genera. In addition, the relatively poor 
immunogenicity of many of the specific and purified an-
tigens seemed to be another limitation14.  
 Recently, identification of the RD1 region in the Mtb 
genome that is absent in BCG and most non-tuberculous 
mycobacteria provided an opportunity o develop new 
specific diagnostic tools by rational design15–17. But this 
approach has other complications, which have to be managed
efficiently1. However, in one study, the RD1 region en-
coded antigens ESAT-6 and CFP-10 and their peptides 
and epitopes were used to study the latency of Mtb infec-
tion in India17.  
 At present, efforts are directed towards the identification 
of newer antigens that are associated with active dise se. 
This type of approach will lead to the development of 
improved strategies for immunodiagnostics of TB. Thus 
the major objective of current immunological studies in TB 
is the identification of species-specific antigens and de-
termination of the significance of corresponding immu e 
responses.  
 In this study, we prepared the sonicate antigens from 
recent and prevalent strains of Mtb which had a single 
copy of insertion element IS6110 and showed 40% of 
prevalence based on our molecular epidemiological stud-
ies18,19. We analysed their protein profiles using SDS–
PAGE and compared their humoral immune response 
with the standard strain H37Rv in normal and TB patients 
by ELISA and Western blot.  
 Totally 13 clinical strains (S1 to S13) obtained from 
BCG trial area of Tiruvallur district, Tamil Nadu formed 
the major clusters by IS6110 and other secondary typing 
methods19,20. Of the total strains infecting in South India, 
the less prevalent (1–2%) strains (S1 and S2, S3) had 
IS6110 insertion at 4.5 kb and 1.0 kb respectively, while 
the most prevalent (38%) strains (S4–S13) had the inser-
tion in hotspot region of Direct Repeat (DR) locus at 
1.5 kb. These clinical isolates were first grown on Lowen-
stein–Jensen’s slopes and then transferred and grown in 
Sauton’s broth medium (without Tween 80) for preparing 
sonicate antigens. The cultures were grown stationary as 
surface pellicle. The sonicate antigens were prepared from 
these strains by sonicating the bacilli in Soniprep 150 as 
described earlier21. The same lot of each antigen was used 
throughout the study to avoid variations. These antigen  
and H37Rv were resolved on 10% SDS–PAGE22 and the 
protein profiles were analysed and compared using the soft-
ware Bio-Capture (Labmate, USA).  
 The blood plasma was collected from 30 PPD-positive 
healthy laboratory volunteers (Nor) and 30 active pulmonary 
TB patients with age ranging from 22 to 60. All the patients 
were sputum smear-positive and were seronegative for 
HIV. Written informed consent was obtained from each 
patient and the study followed the ethical guidelines of 
the Government General Hospital, Chennai.  
 Antibody titre of normal and TB plasma against these 
antigens was determined by ELISA using 5 mg/ml soni-
cate antigen concentration for coating and 1 : 50 dilution 
of plasma which gave the optimum reproducible res lts 
in a linear range. The end colour was read at 450 nm in 
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ELISA reader molecular devices, SPECTRA MAX-250, 
USA. 
 Immunoblot was performed by transferring electropho-
retically resolved proteins onto polyvinylidene difluoride 
membrane (Bio-Rad, USA) and further tested with 1 : 100 
dilution of ten normal and ten tuberculous plasma. The 
molecular weight was calculated with reference to pre-
stained marker (GIBCO, USA). The immunoblots were  
further analysed based on actual molecular weight and 
percentage positivity of each band. Arithmetic mean and 
cut-off values were calculated for antibody ELISA. The 
significance of differences was estimated by Stu ent’s 
paired t-test. 
 Several attempts have been made to purify specific an-
tigens from Mtb for use as diagnostic reagents23. These 
purified antigens and their epitopes gave better specificity 
but could not improve the sensitivity24. To improve the 
sensitivity of the diagnostic test, we need a crude and/or 
complex preparation of antigens with minimum cross-
reactivity. Such antigenic preparations can be obtai ed by 
testing newer antigenic preparations from the recent Mtb 
strains, which are actively involved in infection and trans-
mission of the disease. This model approach can then be 
applied to identify more antigens from other strain pools.  
 Here, we analysed the protein profiles of these sonicate 
antigens and evaluated their diagnostic potential. The pro-
tein profiles showed maximum differences in low molecu-
lar mass region of 10–3  kDa, more distinct in S10and 
S12 antigens (Figure 1). Many studies have shown the 
differential expression of proteins which could be growth 
stage-specific, or associated with virulence factors when  
 
 
 
 
Figure 1. Protein profiles of sonicate antigens (S1–S13) of prevalent 
Mycobacterium tuberculosis strains from clinical isolates. Lane 1, Pro-
tein profile of H37Rv sonicate antigen; lanes 2–14, Sonicate antigens 
from Mtb strains; lane 15, Molecular weight marker. Some differential 
and upregulated protein bands are marked with arrows.  
expressed under stress conditions25. As Mtb strains in this 
study were cultured and harvested under the same culture 
onditions, the observed differences in protei  rofiles 
might be truly differential and may not be directly related 
to virulent factors or growth stage-specific expression. 
Also many studies have evaluated the proteins released 
during growth and shown the importance of low molecu-
lar weight proteins in immunogenicity and immunodiag-
nos ics26–30. Our observations of differential pro eins in S10 
and S12 may prove important in the search of new anti-
gens from these preparations.  
 Antigens of Mtb should be immunogenic and trigger 
appropriate antibody response in infected and TB patients31. 
We studied the antibody response of S1, S2, S10 and S12 
antigens to assess their usefulness in diagnosis. As ex-
pected, significantly high (P < 0.0001) antibody titre was 
obtained in TB plasma against H37Rv, PPD, S1 and S10 
antigens compared to normals (Figure 2). The differenc was 
also greater and significant in pooled TB plasma compared 
to pool normal. The number of patients showing higher 
antibody titre than the cut-off value (mean + 2 SD) was 
19/30 in H37Rv, 18/30 in S1, 15/30 in PPD and 13/30 in 
S10. Only one healthy individual showed antibo y levels 
above cut-off value and hence the false positivity was 
only 3%.  
 Thus the sonicate antigens S1 and S10 showed signifi-
cant increase in antibody levels in TB plasma and were 
comparable with H37Rv, indicating the presence of pote-
tial immunogenic antigens in these clinical strains. It is 
also well established that antibody response during TB 
varies extensively and no single antigen can adequately 
cover such diverse antibody repertoire and therfore yield 
an accurate serodiagnostic assay. To overcome this, recen-
tly, a multi-antigen serological approach had been used 
for diagnosis of TB32,33. The antigen preparation S10, if 
dissected further by 2D gel electrophoresis and purfied 
into individual new proteins, may prove more useful in 
multi-antigen serological approach.  
 Since these are prevalent strains, we are bound to pick 
higher responses to them within the community and in 
patients. Therefore, higher antibody response alone may 
not provide sufficient information regarding the specificity 
of newer epitopes present in the antigens. Hence, these 
quantitative differences were further substantiated with 
the more qualitative data of Western blot.  
 With the differential protein profiles and promising anti-
body response by ELISA, antigens S1 and S10 were furth  
tested using Western blot to decipher if the protein bands 
of differential intensity in PAGE were exclusively recog-
nized by TB antibodies to prove their immunodo inance. 
Surprisingly, in our immunoblot results, S10 alone showed 
specific recognition pattern in low molecular weight re-
gions by only TB plasma showing absolute specificity 
(Figure 3). Immunoblots of H37Rv and S10 were furth  
compared and percentage positivity for each band was 
calculated. For S10 antigen, most of the bands were recog-
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Figure 2. Total IgG antibody levels by ELISA in 30 normal and 30 pulmonary TB patients against various myco-
bacterial sonicate antigens and comparison with standard H37Rv and PPD. Statistical significance s show  as 
*P < 0.0001. 
 
 
 
 
 
Figure 3. Representative immunoblot analysis for H37Rv (a) and S10 (b) antigens with 9 and 8 subjects respectively in both TB and 
normal groups. Prestained molecular weight marker is shown in lane 1. 
 
 
 
nized only by TB plasma with 12–77% positivity. Maxi-
mum positivity was observed for 16 and 45 kDa (77%) 
followed by 38 kDa (66%) protein bands (Figure 4). We 
speculate that such specifically recognized antigens in the 
Western blot of S10 might have contributed to higher anti-
body titre in S10 ELISA results. Many studies have repor-
ted varied antibody response to various antgens of Mtb 
by Western blot34. Recently, new antigens from culture 
filtrate proteins of Mtb were identified for differentiating 
HIV-positive individuals who are at high risk for deve-
loping TB35. 
 The criteria for selection of one antigen preparation out 
of 13 for further purification of immunogenic prot i s were 
based on the differential protein profile and antibody re-
sponse. Although we observed that S2 and S12 showed 
many differential proteins on gel, their discriminatory 
power in antibody ELISA was not good. On the other 
hand, antigen S1 showed few differential bands on SDS–
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Figure 4. Percentage positivity of various protein bands in 10 normals and 10 TB plasmas for H37Rv (a) and S10 (b) antigens was calculated and 
presented graphically. The recognition of each protein band by the number of TB and/or normals was converted into % (percentage positivity). Per-
centage positivity of both TB and normals was drawn against each protein band. 
 
 
 
PAGE but its performance for antibody ELISA was dis-
criminatory, better than PPD and comparable to that of 
H37Rv. Though the protein profiles obs rved on SDS–
PAGE need not reflect in the antibody profiles on ELISA 
or blot, this observation indicates the complexity of the 
protein profiles and their differential response. Moreover, 
the culture of Mtb clini al isolates and H37Rv in stress 
conditions expresses certain proteins, which can be attri-
buted to virulence-associated proteins25. Thus it was dif-
ficult to select the more potent and more discriminatory 
antigen preparation based on the above criteria from these 
widely spread strains in the community.  
 In our earlier study, we found that these sonicate antigens 
induced differential cell-mediated immune responses in 
healthy laboratory volunteers21. Here we further show that 
these antigens have the potential to induce differential 
humoral response. The div rse properties of these antigens 
emphasize their importance in evaluating the diagnostic 
potential, virulence associated factors and various immune 
parameters. In the recent past several studies were conduc-
ted with similar views using many outbreak strains36–40. 
In one such study38 it was shown that clinical strain 
CDC1551 elicited a more vigorous host immune response 
than H37Rv. Analysis of the proteome identified several 
quantitative differences in the cellular protein composition 
of these strains39. A similar type of study was conducted 
with another outbreak strain belonging to the Beijing family 
and a comparison was made for its protein profile and an-
tigen recognition with H37Rv and a less prevalent clinical 
strain. The result of this study showed differences in the 
protein profile which were further attributed to the out-
break strain’s successful spread in the community40.  
 We made use of these basic and preliminary immuno-
logical methods to screen more antigenic preparations 
and found gross differences, which can be used for taper-
ing the search for one or two antigens. By thi  approach 
we could identify some differenc s in SDS–PAGE protein 
profiles for antigens S10 and S12, and strong antibody re-
sponse to S1 (ELISA) and S10 (ELISA and Western 
blot). Although the study uses limited methodology, it in-
vokes convincing scope for further evaluation of these 
strains using state-of-the-art technology in the field of di-
agnostic research. Now we are confining to atigen S10 for 
further studies on purification and characterization of in-
dividual proteins either by conventional procedures or by 
proteomics approach.  
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